NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pharmacology/Insulin and Oral Hypoglycemics
    Insulin and Oral Hypoglycemics
    medium
    pill Pharmacology

    Which of the following is the mechanism by which metformin reduces hepatic glucose output?

    A. Blockade of ATP-sensitive potassium channels in hepatocytes
    B. Inhibition of mitochondrial glycerol-3-phosphate dehydrogenase and suppression of gluconeogenesis
    C. Activation of AMP-activated protein kinase (AMPK) leading to increased insulin secretion
    D. Inhibition of α-glucosidase enzymes in the small intestine

    Explanation

    ## Metformin's Mechanism on Hepatic Glucose Production **Key Point:** Metformin's primary antihyperglycemic effect is suppression of hepatic glucose output (HGO) via inhibition of mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH), which reduces the NAD^+^/NADH ratio and impairs gluconeogenesis. ### Detailed Mechanism 1. **Mitochondrial NADH Accumulation:** Metformin inhibits mGPDH, an enzyme in the inner mitochondrial membrane that catalyzes the oxidation of glycerol-3-phosphate to dihydroxyacetone phosphate. 2. **Reduced NAD^+^ Availability:** This inhibition decreases the NAD^+^/NADH ratio, making NAD^+^ unavailable for other metabolic reactions. 3. **Gluconeogenesis Suppression:** The reduced NAD^+^ impairs the conversion of lactate and pyruvate to glucose in the liver. 4. **Decreased HGO:** Net result is a 20–30% reduction in fasting hepatic glucose output. ### Secondary Mechanisms **High-Yield:** Metformin also: - Increases AMPK activation (indirectly, via energy stress), which inhibits mTORC1 and reduces protein synthesis - Improves peripheral insulin sensitivity (modest effect) - Slows intestinal glucose absorption (minor contribution) - Reduces lactate production (due to decreased gluconeogenesis) ### Comparison: Metformin vs. Other Agents | Agent | Primary Mechanism | Effect on HGO | Effect on Insulin Secretion | |-------|-------------------|---------------|--------------------------| | **Metformin** | mGPDH inhibition → ↓ NAD^+^ | ↓↓ (major) | No direct effect | | Sulfonylureas | K-ATP channel blockade | No direct effect | ↑↑ (major) | | Thiazolidinediones | PPAR-γ agonism | ↓ (modest) | No direct effect | | DPP-4 inhibitors | Incretin prolongation | ↓ (modest) | ↑ (glucose-dependent) | **Clinical Pearl:** Metformin is the first-line agent for type 2 diabetes because it reduces HGO without causing hypoglycemia or weight gain, and it has cardiovascular and renal protective effects [cite:Harrison 21e Ch 417].

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pharmacology Questions